Fassio, Angelo http://orcid.org/0000-0001-9187-232X
Adami, Giovanni
Idolazzi, Luca
Giollo, Alessandro
Viapiana, Ombretta
Bosco, Emma
Negrelli, Riccardo
Sani, Elena
Sandri, Damiano
Mantovani, Alessandro
Targher, Giovanni
Rossini, Maurizio
Gatti, Davide
Article History
Received: 2 July 2020
Accepted: 1 October 2020
First Online: 12 October 2020
Compliance with Ethical Standards
:
: Angelo Fassio reports personal fees from Abiogen, Novartis, and Neopharmed, outside the submitted work. Luca Idolazzi reports personal fees from Eli-Lilly, Merck Sharp & Dohme, Novartis, Sanofi, Celgene, and UCB outside the submitted work. Maurizio Rossini reports personal fees from AbbVie, Abiogen, Eli-Lilly, Merck Sharp & Dohme, Novartis, Sanofi, and UCB, outside the submitted work. Davide Gatti has received advisory board honoraria, consultancy fees, and/or speaker fees from Abiogen, Celgene, Eli-Lilly, Neopharmed-Gentili, Pfizer, and UCB. All other authors do not have anything to disclose.
: The study was conducted within the protocol 1483CESC approved by our local Ethics Committee, in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Written informed consent was obtained from all participants included.